Insider · CIK 0001891712
Alison S Long
Files at TSHA (Taysha Gene Therapies, Inc.). First filing -, latest -.
In brief
Alison S Long files SEC Form 4 as director at TSHA (Taysha Gene Therapies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alison S Long has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Common Stock | +21,335 | $0.00 | $0 | 127,178 | Jun 2, 2026 |
| Jun 1, 2026 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,671 | $0.00 | $0 | 42,671 | Jun 2, 2026 |
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Common Stock | +56,623 | $0.00 | $0 | 105,843 | Jun 4, 2025 |
| Jun 2, 2025 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +113,246 | $0.00 | $0 | 113,246 | Jun 4, 2025 |
| Nov 1, 2023 | TSHA Taysha Gene Therapies, Inc. | AGrant or award Stock Option (right to buy)derivative | +43,800 | $0.00 | $0 | 43,800 | Nov 3, 2023 |
Questions about Alison S Long
Answered from the filings on this page, as of the latest one.
Is Alison S Long buying or selling?
Alison S Long has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alison S Long's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alison S Long has 0.
Where does Alison S Long file Form 4?
Alison S Long has filed Form 4 at TSHA (Taysha Gene Therapies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.